A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload
暂无分享,去创建一个
E. Neufeld | H. Rienhoff | E. Vichinsky | V. Viprakasit | P. Harmatz | J. Kwiatkowski | J. Porter | W. Kramer | D. Chirnomas | L. Tay | A. Tapper